XML 66 R23.htm IDEA: XBRL DOCUMENT
v3.24.3

Restructuring Charges | 9 Months Ended
--- | ---
Sep. 28, 2024
Restructuring Charges [Abstract] |
Restructuring Charges | RESTRUCTURING CHARGES We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, asset impairments, and related consulting fees. The following reflects our restructuring activity (in millions):
| Three Months Ended
| September 28, 2024 |  |
| Supply Chain Reinvention | HRA Pharma Integration | Project Energize | Other Initiatives | Total |  |
Beginning balance | $ | 0.3 |  | $ | 4.9 |  | $ | 37.8 |  | $ | 0.8 |  | $ | 43.8 |  |  |
Additional charges | 2.3 |  | — |  | 14.5 |  | — |  | 16.8 |  |  |
Payments | (1.9) |  | (0.5) |  | (13.5) |  | (0.4) |  | (16.3) |  |  |
Non-cash adjustments | — |  | — |  | — |  | — |  | — |  |  |
Ending balance | $ | 0.7 |  | $ | 4.4 |  | $ | 38.8 |  | $ | 0.4 |  | $ | 44.3 |  |  |
| Nine Months Ended
| September 28, 2024 |  |
| Supply Chain Reinvention | HRA Pharma Integration | Project Energize | Other Initiatives | Total |  |
Beginning balance | $ | 0.7 |  | $ | 6.8 |  | $ | 2.9 |  | $ | 1.8 |  | $ | 12.2 |  |  |
Additional charges | 7.3 |  | — |  | 90.6 |  | 0.2 |  | 98.1 |  |  |
Payments | (7.0) |  | (2.4) |  | (43.5) |  | (1.7) |  | (54.6) |  |  |
Non-cash adjustments | (0.3) |  | — |  | (11.2) |  | 0.1 |  | (11.4) |  |  |
Ending balance | $ | 0.7 |  | $ | 4.4 |  | $ | 38.8 |  | $ | 0.4 |  | $ | 44.3 |  |  |
| Three Months Ended
| September 30, 2023
| Supply Chain Reinvention | HRA Pharma Integration | Other Initiatives | Total
Beginning balance | $ | — |  | $ | 9.6 |  | $ | 3.8 |  | $ | 13.4 |
Additional charges | 13.5 |  | 0.5 |  | 1.5 |  | 15.5 |
Payments | (2.3) |  | (4.0) |  | (2.8) |  | (9.0) |
Non-cash adjustments | (11.2) |  | (0.1) |  | (0.4) |  | (11.7) |
Ending balance | $ | — |  | $ | 6.0 |  | $ | 2.2 |  | $ | 8.2 |
| Nine Months Ended
| September 30, 2023
| Supply Chain Reinvention | HRA Pharma Integration | Other Initiatives | Total
Beginning balance | $ | 2.2 |  | $ | 13.3 |  | $ | 4.3 |  | $ | 19.8 |
Additional charges | 17.4 |  | 2.7 |  | 5.6 |  | 25.7 |
Payments | (8.4) |  | (10.1) |  | (7.8) |  | (26.3) |
Non-cash adjustments | (11.2) |  | 0.1 |  | 0.1 |  | (11.0) |
Ending balance | $ | — |  | $ | 6.0 |  | $ | 2.2 |  | $ | 8.2 |
The charges incurred during the three and nine months ended September 28, 2024 were primarily associated with actions taken on Project Energize activities associated with employee separation, consulting fees and lease exit costs. The charges incurred during the three and nine months ended September 30, 2023 were primarily associated with actions taken on our multi-year supply chain restructuring program initiative started in 2022, and HRA Pharma integration activities associated with employee separation, continuity and other benefit-related costs. Of the amount recorded during the three and nine months ended September 28, 2024, $9.1 million and $48.8 million was related to our CSCI segment and $5.4 million and $23.8 million related to our CSCA segment, and $2.3 million and $25.5 million was related to our Unallocated segment. For all segments, amounts were due primarily to Project Energize. Of the amount recorded during the three and nine months ended September 30, 2023, $12.5 million and $19.2 million was related to our CSCI segment, due primarily to supply chain restructuring (including the $11.2 million asset impairment) and HRA Pharma integration initiatives, and $2.3 million and $4.6 million was related to our CSCA segment, also due primarily to supply chain restructuring initiatives. There were no other material restructuring programs for the periods presented. All charges are recorded in Restructuring expense on the Condensed Consolidated Statements of Operations. The remaining $44.3 million liability for employee severance benefits and consulting fees is expected to be mostly paid within the next year.

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration